A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerDavid J. Hunter, Stephen J. Chanock, Robert N. Hoover et al.|Nature Genetics|2007Cited by 1.5k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B. Daly, Mary A. Dwyer, Tuya Pal et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 1.1k
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B. Daly, Susan Darlow, Robert Pilarski et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 660
Genetic/Familial High-Risk Assessment: Breast and OvarianMary B. Daly, Jeffrey N. Weitzel, Jennifer E. Axilbund et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 650
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)Gilles Thomas, David J. Hunter, Kevin B. Jacobs et al.|Nature Genetics|2009Cited by 546